| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | Australia | 3 | |
| #4 | Canada | 3 | |
| #5 | United States | 3 | |
| #6 | China | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Measurement | |
| #3 | Computer technology | |
| #4 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Analysing materials | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Measuring microorganism processes | |
| #5 | Healthcare informatics |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wolff-Winiski Barbara | 18 |
| #2 | Stütz Anton | 14 |
| #3 | Dörfler Petra | 14 |
| #4 | Stutz Anton | 3 |
| #5 | Dorfler Petra | 3 |
| #6 | Schöfmann Nicole | 1 |
| #7 | Stuetz Anton | 1 |
| #8 | Doerfler Petra | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020152193A1 | Selective glucocorticoid receptor modifiers for treating impaired skin wound healing | |
| CA3096136A1 | Rucaparib, talazoparib, veliparib, olaparib and azd 2461 for treating impaired skin wound healing | |
| EP3615026A1 | A parp inhibitor in combination with a glucocorticoid and/or ascorbic acid and/or a protein growth factor for the treatment of impaired wound healing | |
| EP3312608A1 | Methods for identifying a non-healing skin wound and for monitoring the healing of a skin wound |